Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia

Digestive Diseases and Sciences

Volumn 56, Issue 7, 2011, Pages 2166-2178

  Buscarini, Elisabetta ^a,h   Leandro, Gioacchino ^b   Conte, Dario ^c   Danesino, Cesare ^d   Daina, Erica ^e   Manfredi, Guido ^a   Lupinacci, Guido ^a   Brambilla, Gianfranco ^a   Menozzi, Fernanda ^a   De Grazia, Federico ^a   Gazzaniga, Pietro ^a   Inama, Giuseppe ^a   Bonardi, Roberto ^a   Blotta, Pasquale ^a   Forner, Pierangelo ^a   Olivieri, Carla ^d   Perna, Annalisa ^e   Grosso, Maurizio ^f   Pongiglione, Giacomo ^g   Boccardi, Edoardo ^h   Pagella, Fabio ⁱ   Rossi, Giorgio ^c   Zambelli, Alessandro ^a   more..

^a MAGGIORE HOSPITAL   (Italy)

^b Gastroenterology Unit 1   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^f S CROCE E CARLE HOSPITAL   (Italy)

^g BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^h OSPEDALE NIGUARDA CA GRANDA   (Italy)

ⁱ FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Gastrointestinal bleeding; Heart failure; Hereditary hemorrhagic telangiectasia; Liver transplantation; Liver vascular malformations; Portal hypertension

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IRON;

ADOLESCENT; ADULT; AGED; ANEMIA; ANGINA PECTORIS; ANTIBIOTIC THERAPY; ARTICLE; ASCITES; BRAIN DISEASE; CARDIOVERSION; CATHETER ABLATION; CHILD; CHOLANGITIS; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; EPISTAXIS; EVENT FREE SURVIVAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HIGH OUTPUT HEART FAILURE; HISTORY; HUMAN; INCIDENCE; ITALY; LIVER; LIVER DISEASE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVER VASCULAR MALFORMATION; MAJOR CLINICAL STUDY; MALE; MESENTERIC ANGINA; MESENTERIC ARTERY OCCLUSION; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PORTAL HYPERTENSION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENDU OSLER WEBER DISEASE; RISK FACTOR; SCHOOL CHILD; SCREENING TEST; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTERIOVENOUS MALFORMATIONS; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATIC ARTERY; HEPATIC VEINS; HUMANS; LIVER; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79959759416     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1585-2     Document Type: Article

References (49)

1. Guttmacher AE, Marchuk DA, White RI. Hereditary hemorrhagic telangiectasia. NEJM. 1995;333:918-924.
2. Dakeishi M, Shioya T, Wada Y, et al. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat. 2002;19:140-148. (Pubitemid 34121805)
3. Govani FS, Shovlin CL. Hereditary hemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Gen. 2009;17:860-871.
4. Abdalla SA, Letarte M. Hereditary hemorrhagic telangiectasia: current views on genetics and mechanism of disease. J Med Genet. 2006;43:97-110. (Pubitemid 43262964)
5. Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med. 1999;245:31-39. (Pubitemid 29049140)
6. Bideau A, Brunet G, Heyer E, et al. An abnormal concentration of cases of Rendu-Osler disease in the Valserine valley of the French Jura: a genealogical and demographic study. Ann Hum Biol. 1992;19:233-247.
7. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Osler-Weber- Rendu syndrome). Am J Med Genet. 2000;91:66-67. (Pubitemid 30127562)
8. McDonald MT, Papenberg KA, Ghosh S, et al. A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34. Nat Genet. 1994;6:197-204. (Pubitemid 24188603)
9. Shovlin C, Hughes JMB, Tuddenham EGD, et al. A gene for hereditary hemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet. 1994;6:205-209. (Pubitemid 24188604)
10. Vincent P, Plauchu H, Hazan J, et al. A third locus for hereditary hemorrhagic telangiectasia maps to chromosome 12q. Hum Mol Genet. 1995;4:945-949.
11. Johnson DW, Berg JN, Baldwin MA, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary hemorrhagic telangiectasia type 2. Nat Genet. 1996;13:189-195.
12. Gallione CJ, Repetto GM, Legius E, et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet. 2004;363: 852-859. (Pubitemid 38368834)
13. Cole SG, Begbie ME, Wallace GM. Shovlin CLA new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet. 2005;42:577-582. (Pubitemid 40993833)
14. Bayrak-Toydemir P, McDonald J, Akarsu N, et al. A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet. 2006;140:2155-2162. (Pubitemid 44522429)
15. Buscarini E, Danesino C, Olivieri C, et al. Doppler ultrasonographic grading of hepatic vascular malformations in hereditary hemorrhagic telangiectasia: results of extensive screening. Ultraschall Med. 2004;25:348-355. (Pubitemid 39304438)
16. Stabile Ianora AA, Memeo M, Sabbà C, et al. Hereditary hemorrhagic telangiectasia: multi-detector row helical CT assessment of hepatic involvement. Radiology. 2004;230:350-359.
17. Bayrak-Toydemir P, McDonald J, Markewitz B, et al. Genotypephenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations. Am J Med Genet A. 2006;140: 463-470. (Pubitemid 43376318)
18. Lesca G, Olivieri C, Burnichon N, et al. Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network. Genet Med. 2007;9:14-22. (Pubitemid 46105845)
19. Sabbà C, Pasculli G, Lenato GM, et al. Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost. 2007;5:1149-1157. (Pubitemid 46902115)
20. Letteboer TG, Mager JJ, Snijder RJ, et al. Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet. 2006;43:371-377.
21. Brakensiek K, Frye-Boukhriss H, Mälzer M, et al. Detection of a significant association between mutations in the ACVRL1 gene and hepatic involvement in German patients with hereditary haemorrhagic telangiectasia. Clin Genet. 2008;74:171-177. (Pubitemid 351974278)
22. Fernandez-L A, Sanz-Rodriguez F, Zarrabeitia R, et al. Blood outgrowth endothelial cells from hereditary haemorrhagic telangiectasia patients reveal abnormalities compatible with vascular lesions. Cardiovasc Res. 2005;68:235-248. (Pubitemid 41428420)
23. Buscarini E, Danesino C, Olivieri C, et al. Liver involvement in hereditary haemorrhagic telangiectasia or Rendu-Osler-Weber disease. Dig Liver Dis. 2005;37:635-645. (Pubitemid 44356078)
24. Shovlin CL, Winstock AR, Peters AM, et al. Medical complications of pregnancy in hereditary haemorrhagic telangiectasia. QJM. 1995;88:879-887. (Pubitemid 26009655)
25. Buscarini E, Plauchu H, GarciaTsao G, et al. Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations. Liver Int. 2006;26:1040-1046. (Pubitemid 44541744)
26. Garcia-Tsao G, Korzenik J, Young L, et al. Liver disease in patientswith hereditary hemorrhagic telangiectasia.NEJM. 2000;343: 931-936.
27. Khalid SK, Garcia-Tsao G. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia. Semin Liver Dis. 2008;28: 247-258.
28. Gincul R, Lesca G, Gelas-Dore B, et al. Evaluation of previously non screened hereditary hemorrhagic telangiectasia patients shows frequent liver involvement and early cardiac consequences. Hepatology. 2008;48:1570-1576.
29. Shovlin CL, Tighe HC, Davies RJ, et al. Embolisation of pulmonary arteriovenous malformations: no consistent effect on pulmonary artery pressure. Eur Respir J. 2008;32:162-169.
30. Shovlin CL, Sodhi V, McCarthy A, et al. Estimates of maternal risks of pregnancy for women with hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): suggested approach for obstetric services. BJOG. 2008;115:1108-1115. (Pubitemid 352000361)
31. Goussous T, Haynes A, Najarian K, et al. Hereditary hemorrhagic telangiectasia presenting as high output cardiac failure during pregnancy. Cardiol Res Pract. 2009;2009:437237.
32. Faughnan ME, Palda VA, Garcia-Tsao G, et al. International guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. J Med Genet. 2011;48:73-87.
33. Caselitz M, Bahr MJ, Bleck JS, et al. Sonographic criteria for the diagnosis of hepatic involvement in hereditary hemorrhagic telangiectasia (HHT). Hepatology. 2003;37:1139-1146. (Pubitemid 36538691)
34. DeLeve LD, Valla DC, Garcia-Tsao G. American association for the study liver diseases. Vascular disorders of the liver. Hepatology. 2009;49:1729-1764.
35. Dupuis-Girod S, Chesnais AL, Ginon I, et al. Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single- center study. Liver Transpl. 2010;16:340-347.
36. Colli A, Fraquelli M, Andreoletti M, et al. Severe liver fibrosis or cirrhosis: accuracy of US for detection-analysis of 300 cases. Radiology. 2003;227:89-94. (Pubitemid 36384184)
37. Buscarini E, Buscarini L, Civardi G, et al. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: imaging findings. AJR. 1994;163:1105-1110. (Pubitemid 24355700)
38. Buscarini E, Buscarini L, Danesino C, et al. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia-Doppler sonographic screening in a large family. J Hepatol. 1997;26: 111-118. (Pubitemid 27072612)
39. Buscarini E, Danesino C, Plauchu H, et al. High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia. Ultrasound Med Biol. 2004;30: 1089-1097. (Pubitemid 39531615)
40. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Eur Heart J. 2008;29:2388-2442.
41. Garcia-Tsao G. Liver involvement in hereditary hemorrhagic telangiectasia (HHT). J Hepatol. 2007;46:499-507. (Pubitemid 46185709)
42. Blewitt RW, Brown CM, Wyatt JI. The pathology of acute hepatic disintegration in hereditary hemorrhagic telangiectasia. Histopathology. 2003;42:265-269. (Pubitemid 36356859)
43. Bueres Dominguez I, Annet L, Waignein F, et al. Extensive ischemic liver necrosis complicating hereditary hemorrhagic telangiectasia: a rare indication for liver transplantation. Liver Int. 2005;25:677-679. (Pubitemid 40861917)
44. Mc Inroy B, Zajko AB, Pinna AD. Biliary necrosis due to hepatic involvement with hereditary hemorrhagic telangiectasia. AJR. 1998;170:413-415. (Pubitemid 28083849)
45. Buscarini E, Gebel M, Ocran K, et al. Interobserver agreement in diagnosing liver involvement in hereditary hemorrhagic telangiectasia by Doppler ultrasound. Ultrasound Med Biol. 2008;34: 718-725. (Pubitemid 351608047)
46. Buonamico P, Suppressa P, Lenato GM, et al. Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: echo-color Doppler versus multislice CT study. J Hepatol. 2008;48:811-820.
47. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W, The Practice Guidelines Committee of the American Association for the Study of Liver Diseases, the Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophagealvarices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922-937.
48. Mitchell A, Adams LA, MacQuillan G, et al. Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia. Liver Transpl. 2008;14:210-213. (Pubitemid 351267278)
49. Buscarini E, Manfredi G, Zambelli A. Bevacizumab to treat complicated liver vascular malformations in hereditary hemorrhagic telangiectasia: a word of caution. Liver Transpl. 2008;14: 1685-1686.